Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Pediatrix Medical Group, Inc. MD

Full chart Compare
Set alert

Price alert · MD

All alert types
30.60 USD -0.11 (-0.36%)

At closeNov 3, 2026, 4:32 PM EST

30.60 0.00 0.00%

After hours · Nov 3, 4:32 PM ET

29.76 Day range 30.95
17.23 52-week range 31.07
YTD
+43.06%
1 year
+45.16%

Financial health

Altman Z-Score

2.46 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 3
  • P/B 3

Valuation

P/E 11.0×
FY 2016: 19.2×FY 2017: 15.6×FY 2018: 11.2×FY 2019: -1.6×FY 2020: -2.6×FY 2021: 17.9×FY 2022: 18.6×FY 2023: -12.7×FY 2024: -11.0×FY 2025: 11.0×
FY 2016 5y median 11.0× FY 2025
P/S 1.0×
FY 2016: 1.9×FY 2017: 1.4×FY 2018: 0.8×FY 2019: 1.3×FY 2020: 1.2×FY 2021: 1.2×FY 2022: 0.6×FY 2023: 0.4×FY 2024: 0.5×FY 2025: 1.0×
FY 2016 5y median 0.6× FY 2025
P/B 2.1×
FY 2016: 2.2×FY 2017: 1.6×FY 2018: 1.0×FY 2019: 1.6×FY 2020: 2.8×FY 2021: 2.6×FY 2022: 1.4×FY 2023: 0.9×FY 2024: 1.4×FY 2025: 2.1×
FY 2016 5y median 1.4× FY 2025
P/FCF 7.2×
FY 2016: 15.2×FY 2017: 10.7×FY 2018: 12.5×FY 2019: 6.9×FY 2020: 11.9×FY 2021: 52.9×FY 2022: 9.0×FY 2023: 7.4×FY 2024: 5.9×FY 2025: 7.2×
FY 2016 5y median 7.4× FY 2025
EV/EBITDA 7.7×
FY 2016: 11.8×FY 2017: 11.5×FY 2018: 10.6×FY 2019: 19.8×FY 2020: 19.0×FY 2021: 12.8×FY 2022: 12.4×FY 2023: 46.6×FY 2024: -53.8×FY 2025: 7.7×
FY 2016 5y median 12.4× FY 2025
EV/Sales 1.1×
FY 2016: 2.5×FY 2017: 1.9×FY 2018: 1.4×FY 2019: 2.3×FY 2020: 1.6×FY 2021: 1.6×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 0.8×FY 2025: 1.1×
FY 2016 5y median 1.0× FY 2025
FCF Yield 13.9%
FY 2016: 6.6%FY 2017: 9.4%FY 2018: 8.0%FY 2019: 14.5%FY 2020: 8.4%FY 2021: 1.9%FY 2022: 11.1%FY 2023: 13.6%FY 2024: 16.9%FY 2025: 13.9%
FY 2016 5y median 13.6% FY 2025

Profitability

Gross Margin 24.7%
FY 2016: 32.5%FY 2017: 28.9%FY 2018: 27.1%FY 2019: 28.3%FY 2020: 25.9%FY 2021: 26.9%FY 2022: 23.7%FY 2023: 21.1%FY 2024: 22.6%FY 2025: 24.7%
FY 2016 5y median 23.7% FY 2025
Operating Margin 12.1%
FY 2016: 18.0%FY 2017: 13.9%FY 2018: 12.2%FY 2019: 9.7%FY 2020: 5.7%FY 2021: 10.6%FY 2022: 8.8%FY 2023: 0.4%FY 2024: -3.4%FY 2025: 12.1%
FY 2016 5y median 8.8% FY 2025
Net Margin 8.6%
FY 2016: 10.2%FY 2017: 9.3%FY 2018: 7.4%FY 2019: -84.2%FY 2020: -45.9%FY 2021: 6.9%FY 2022: 3.4%FY 2023: -3.0%FY 2024: -4.9%FY 2025: 8.6%
FY 2016 5y median 3.4% FY 2025
ROE 19.1%
FY 2016: 11.8%FY 2017: 10.4%FY 2018: 8.7%FY 2019: -99.9%FY 2020: -106.6%FY 2021: 14.6%FY 2022: 7.4%FY 2023: -7.1%FY 2024: -13.0%FY 2025: 19.1%
FY 2016 5y median 7.4% FY 2025
ROIC 9.7%
FY 2016: 7.3%FY 2017: 6.9%FY 2018: 5.9%FY 2019: 3.4%FY 2020: -4.5%FY 2021: 7.0%FY 2022: 6.8%FY 2023: 0.4%FY 2024: -3.8%FY 2025: 9.7%
FY 2016 5y median 6.8% FY 2025
ROA 7.4%
FY 2016: 6.1%FY 2017: 5.5%FY 2018: 4.5%FY 2019: -36.1%FY 2020: -23.8%FY 2021: 4.8%FY 2022: 2.8%FY 2023: -2.7%FY 2024: -4.6%FY 2025: 7.4%
FY 2016 5y median 2.8% FY 2025

Growth (YoY)

Revenue -4.9%
FY 2016: 14.5%FY 2017: 8.6%FY 2018: 5.5%FY 2019: -51.2%FY 2020: -2.6%FY 2021: 10.2%FY 2022: 3.2%FY 2023: 1.1%FY 2024: 0.9%FY 2025: -4.9%
FY 2016 FY 2025
Operating Income 436.3%
FY 2016: 2.5%FY 2017: -16.0%FY 2018: -7.1%FY 2019: -61.5%FY 2020: -42.9%FY 2021: 106.8%FY 2022: -14.9%FY 2023: -95.8%FY 2024: -1038.6%FY 2025: 436.3%
FY 2016 FY 2025
EPS (diluted) 263.0%
FY 2016: -3.1%FY 2017: -1.4%FY 2018: -14.3%FY 2019: -712.3%FY 2020: 46.8%FY 2021: 115.9%FY 2022: -48.0%FY 2023: -192.4%FY 2024: -63.0%FY 2025: 263.0%
FY 2016 FY 2025
Free Cash Flow 36.9%
FY 2016: 18.4%FY 2017: 14.2%FY 2018: -47.8%FY 2019: 40.4%FY 2020: -48.0%FY 2021: -74.7%FY 2022: 208.5%FY 2023: -24.2%FY 2024: 77.5%FY 2025: 36.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.7×
FY 2016: 1.4×FY 2017: 1.4×FY 2018: 1.4×FY 2019: 1.4×FY 2020: 3.5×FY 2021: 2.0×FY 2022: 1.0×FY 2023: 1.2×FY 2024: 1.5×FY 2025: 1.7×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.7×
FY 2016: 1.4×FY 2017: 1.4×FY 2018: 1.4×FY 2019: 1.4×FY 2020: 3.5×FY 2021: 2.0×FY 2022: 1.0×FY 2023: 1.2×FY 2024: 1.5×FY 2025: 1.7×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.8×
FY 2016: 0.6×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 1.2×FY 2020: 2.4×FY 2021: 1.2×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 1.0×
FY 2016: 2.5×FY 2017: 3.0×FY 2018: 4.1×FY 2019: 8.3×FY 2020: 4.7×FY 2021: 2.9×FY 2022: 4.5×FY 2023: 21.0×FY 2024: -15.2×FY 2025: 1.0×
FY 2016 5y median 2.9× FY 2025
Interest Coverage 6.4×
FY 2016: 9.1×FY 2017: 6.4×FY 2018: 4.8×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 3.0×FY 2022: 4.4×FY 2023: 0.2×FY 2024: -1.7×FY 2025: 6.4×
FY 2016 5y median 3.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31